Design of a Microfluidic Bleeding Chip to Evaluate Antithrombotic Agents for Use in COVID-19 Patients

INTRODUCTION: Interventions that could prevent thrombosis, clinical decompensation, and respiratory compromise in patients with novel coronavirus disease (COVID-19) are key to decrease mortality rate. Studies show that profound cytokine release and excessive activation of blood coagulation appear to...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Mol Bioeng
Autori principali: Lakshmanan, Hari Hara Sudhan, Pore, Adity A., Kohs, Tia C. L., Yazar, Feyza, Thompson, Rachel M., Jurney, Patrick L., Maddala, Jeevan, Olson, Sven R., Shatzel, Joseph J., Vanapalli, Siva A., McCarty, Owen J. T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Covid-19
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408976/
https://ncbi.nlm.nih.gov/pubmed/32837586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12195-020-00644-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi